Cloudflare Inc vs Recursion Pharmaceuticals Inc — how do they compare? Cloudflare Inc trades at $271.1 (market cap $96.69B), while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: Cloudflare Inc is far larger — about 63.2× Recursion Pharmaceuticals Inc's market cap, and Cloudflare Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| NET | RXRX | |
|---|---|---|
Market Cap | $96.69B | $1.53B |
Sector | Technology | Health |
52-Week High | $281.69 | $6.79 |
52-Week Low | $160.16 | $2.84 |
Enterprise Value | $96.05B | $946.50M |
Trailing returns across standard periods
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →